Publicaciones en las que colabora con José Antonio López Guerrero (28)

2012

  1. CCL27-CCR10 and CXCL12-CXCR4 chemokine ligand-receptor mRNA expression ratio: New predictive factors of tumor progression in cutaneous malignant melanoma

    Clinical and Experimental Metastasis, Vol. 29, Núm. 6, pp. 625-637

  2. Characterization of a new human cell line (CH-3573) derived from a grade II chondrosarcoma with matrix production

    Pathology and Oncology Research, Vol. 18, Núm. 4, pp. 793-802

2011

  1. Clinicopathological significance of cell cycle regulation markers in a large series of genetically confirmed Ewing's Sarcoma Family of Tumors

    International Journal of Cancer, Vol. 128, Núm. 5, pp. 1139-1150

  2. Dermatofibrosarcoma protuberans: A clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors

    Journal of the American Academy of Dermatology, Vol. 65, Núm. 3, pp. 564-575

  3. Evaluation of prognostic factors and their capacity to predict biological behavior in gastrointestinal stromal tumors

    International Journal of Surgical Pathology, Vol. 19, Núm. 4, pp. 448-461

2010

  1. Valor de la expresión inmunohistoquímica de CD117 y del estudio molecular de c-KIT y PDGFRα en la redefinición diagnóstica de una serie retrospectiva de tumores mesenquimales del tracto gastrointestinal

    Revista Espanola de Patologia, Vol. 43, Núm. 3, pp. 139-143

2009

  1. Inflammatory fibroid polyp of the small bowel with a mutation in exon 12 of PDGFRα

    Virchows Archiv, Vol. 454, Núm. 3, pp. 327-331

  2. Molecular diagnosis of ewing sarcoma family of tumors: A comparative analysis of 560 cases with fish and rt-pcr

    Diagnostic Molecular Pathology, Vol. 18, Núm. 4, pp. 189-199

2008

  1. Atrophic dermatofibrosarcoma protuberans with the fusion gene COL1A1-PDGFB [8]

    Journal of the European Academy of Dermatology and Venereology

  2. Tissue microarrays: Applications in study of p16 and p53 alterations in Ewing's cell lines

    Diagnostic Pathology

2007

  1. Concurrent EGFR amplification and TP-53 mutation in glioblastomas

    Clinical Neuropathology, Vol. 26, Núm. 5, pp. 224-231

2006

  1. Análisis del gen de fusión COL1A1-PDGFB en un caso de dermatofibrosarcoma protuberans con componente de fibrosarcoma

    Actas Dermo-Sifiliograficas, Vol. 97, Núm. 5, pp. 337-341

  2. Desmoplastic infantile ganglioglioma. Morphological, immunohistochemical and genetic features [8]

    Histopathology

  3. HER2 amplification in recurrent breast cancer following breast-conserving therapy correlates with distant metastasis and poor survival

    International Journal of Cancer, Vol. 118, Núm. 7, pp. 1743-1749

  4. Molecular and Immunohistochemical Analysis of the Prognostic Value of Cell-Cycle Regulators in Urothelial Neoplasms of the Bladder

    European Urology, Vol. 50, Núm. 3, pp. 506-515

  5. Primary glioblastoma with EGFR amplification and a ring chromosome 7 in a young patient

    Clinical Neuropathology, Vol. 25, Núm. 4, pp. 193-199

  6. Tissue microarray profiling of primary and xenotransplanted synovial sarcomas demonstrates the immunophenotypic similarities existing between SYT-SSX fusion gene confirmed, biphasic, and monophasic fibrous variants

    Virchows Archiv, Vol. 449, Núm. 4, pp. 435-447

2005

  1. Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme

    Clinical Neuropathology, Vol. 24, Núm. 5, pp. 209-218

  2. Mutational analysis of the c-KIT and PDGFRα in a series of molecularly well-characterized synovial sarcomas

    Diagnostic Molecular Pathology, Vol. 14, Núm. 3, pp. 134-139

2004

  1. Deregulation of the G1 to S-phase cell cycle checkpoint is involved in the pathogenesis of human osteosarcoma

    Diagnostic Molecular Pathology, Vol. 13, Núm. 2, pp. 81-91